Literature DB >> 17553802

Differential regulation of ATP binding cassette protein A1 expression and ApoA-I lipidation by Niemann-Pick type C1 in murine hepatocytes and macrophages.

Ming-Dong Wang1, Vivian Franklin, Meenakshi Sundaram, Robert S Kiss, Kenneth Ho, Michel Gallant, Yves L Marcel.   

Abstract

Niemann-Pick type C1 (Npc1) protein inactivation results in lipid accumulation in late endosomes and lysosomes, leading to a defect of ATP binding cassette protein A1 (Abca1)-mediated lipid efflux to apolipoprotein A-I (apoA-I) in macrophages and fibroblasts. However, the role of Npc1 in Abca1-mediated lipid efflux to apoA-I in hepatocytes, the major cells contributing to HDL formation, is still unknown. Here we show that, whereas lipid efflux to apoA-I in Npc1-null macrophages is impaired, the lipidation of endogenously synthesized apoA-I by low density lipoprotein-derived cholesterol or de novo synthesized cholesterol or phospholipids in Npc1-null hepatocytes is significantly increased by about 1-, 3-, and 8-fold, respectively. The increased cholesterol efflux reflects a major increase of Abca1 protein in Npc1-null hepatocytes, which contrasts with the decrease observed in Npc1-null macrophages. The increased Abca1 expression is largely post-transcriptional, because Abca1 mRNA is only slightly increased and Lxr alpha mRNA is not changed, and Lxr alpha target genes are reduced. This differs from the regulation of Abcg1 expression, which is up-regulated at both mRNA and protein levels in Npc1-null cells. Abca1 protein translation rate is higher in Npc1-null hepatocytes, compared with wild type hepatocytes as measured by [(35)S]methionine incorporation, whereas there is no difference for the degradation of newly synthesized Abca1 in these two types of hepatocytes. Cathepsin D, which we recently identified as a positive modulator of Abca1, is markedly increased at both mRNA and protein levels by Npc1 inactivation in hepatocytes but not in macrophages. Consistent with this, inhibition of cathepsin D with pepstatin A reduced the Abca1 protein level in both Npc1-inactivated and WT hepatocytes. Therefore, Abca1 expression is specifically regulated in hepatocytes, where Npc1 activity modulates cathepsin D expression and Abca1 protein translation rate.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17553802     DOI: 10.1074/jbc.M700326200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

Review 1.  MicroRNAs regulating lipid metabolism in atherogenesis.

Authors:  K J Rayner; C Fernandez-Hernando; K J Moore
Journal:  Thromb Haemost       Date:  2012-01-25       Impact factor: 5.249

2.  Lysosomal acid lipase deficiency impairs regulation of ABCA1 gene and formation of high density lipoproteins in cholesteryl ester storage disease.

Authors:  Kristin L Bowden; Nicolas J Bilbey; Leanne M Bilawchuk; Emmanuel Boadu; Rohini Sidhu; Daniel S Ory; Hong Du; Teddy Chan; Gordon A Francis
Journal:  J Biol Chem       Date:  2011-07-10       Impact factor: 5.157

3.  Cyclodextrin has conflicting actions on autophagy flux in vivo in brains of normal and Alzheimer model mice.

Authors:  Dun-Sheng Yang; Philip Stavrides; Asok Kumar; Ying Jiang; Panaiyur S Mohan; Masuo Ohno; Kostantin Dobrenis; Cristin D Davidson; Mitsuo Saito; Monika Pawlik; Chunfeng Huo; Steven U Walkley; Ralph A Nixon
Journal:  Hum Mol Genet       Date:  2017-03-01       Impact factor: 6.150

4.  Hepatic deficiency of low density lipoprotein receptor-related protein-1 reduces high density lipoprotein secretion and plasma levels in mice.

Authors:  Joshua E Basford; Lauren Wancata; Susanna M Hofmann; R A Gangani D Silva; W Sean Davidson; Philip N Howles; David Y Hui
Journal:  J Biol Chem       Date:  2011-02-22       Impact factor: 5.157

5.  Niemann-Pick C2 protein expression regulates lithogenic diet-induced gallstone formation and dietary cholesterol metabolism in mice.

Authors:  Elisa Balboa; Gabriela Morales; Paula Aylwin; Gonzalo Carrasco; Ludwig Amigo; Juan Castro; Attilio Rigotti; Silvana Zanlungo
Journal:  Lipids       Date:  2011-10-30       Impact factor: 1.880

6.  LAL (Lysosomal Acid Lipase) Promotes Reverse Cholesterol Transport In Vitro and In Vivo.

Authors:  Kristin L Bowden; Joshua A Dubland; Teddy Chan; You-Hai Xu; Gregory A Grabowski; Hong Du; Gordon A Francis
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-03-29       Impact factor: 8.311

7.  Overexpression of STARD3 in human monocyte/macrophages induces an anti-atherogenic lipid phenotype.

Authors:  Faye Borthwick; Anne-Marie Allen; Janice M Taylor; Annette Graham
Journal:  Clin Sci (Lond)       Date:  2010-06-22       Impact factor: 6.124

8.  Interaction of functional NPC1 gene polymorphism with smoking on coronary heart disease.

Authors:  Weiwei Ma; Jing Xu; Qianqian Wang; Ying Xin; Lin Zhang; Xinxin Zheng; Hu Wang; Kai Sun; Rutai Hui; Xiaohong Huang
Journal:  BMC Med Genet       Date:  2010-10-18       Impact factor: 2.103

9.  Enhancing apolipoprotein A-I-dependent cholesterol efflux elevates cholesterol export from macrophages in vivo.

Authors:  Nigora Mukhamedova; Genevieve Escher; Wilissa D'Souza; Urbain Tchoua; Angela Grant; Zigmund Krozowski; Michael Bukrinsky; Dmitri Sviridov
Journal:  J Lipid Res       Date:  2008-07-12       Impact factor: 5.922

10.  ARF6-mediated endosome recycling reverses lipid accumulation defects in Niemann-Pick Type C disease.

Authors:  Jill Kuglin Schweitzer; Sean D Pietrini; Crislyn D'Souza-Schorey
Journal:  PLoS One       Date:  2009-04-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.